Objective: We analysed the Qatar stroke registry for ethnic variations in patients admitted with cerebrovascular disease at Hamad General Hospital, Qatar. Methods: Patients admitted with acute stroke from January 2014 to December 2015, enrolled in the registry were included in the study. We evaluated the clinical presentation, risk factors, and outcome at discharge and 90 days postdischarge in relation to the patient's ethnic background. Results: A total of 1727 patients were enrolled in the Hamad General Hospital stroke registry (Middle Eastern 594 (34.4%), South East Asian 924 (53.5%) and Far Eastern 209 (12.1%)). There were significant differences in risk factors, clinical presentation and prognosis. Compared to Middle Eastern patients, Far Eastern patients were younger (62.8 AE 13.7 vs. 48.9 AE 9.1 years; p < 0.001). Diabetes and hypertension were significantly more common in Middle Eastern patients (358 (60.3%), 458 (77.1%)) compared to South East Asian patients (420 (45.5%), 596 (64.5%)) and Far Eastern patients (57 (27.3%), 154 (73.7%)), respectively (p < 0.001). Stroke was more severe in the Far Eastern group (median (interquartile range) -5.0 (2-11.5)) compared to the Middle Eastern group (median (interquartile range) -4.0 (1-8)) and South East Asian (median (interquartile range) -4.0 (2-9)), p ¼ 0.011. Mortality at 90 days was highest in patients from the Far East (15/209 (8.2%)) compared to the Middle East (35/594 (6.5%)) and South East Asia (33/924 (4.0)), p ¼ 0.028. Patients from the Far East had significantly higher rates of intracranial hemorrhage compared to the Middle East and South East Asia (70/209 (33.5%), 77/594 (13.0%), and 169/924 (18.3%)), respectively (p < 0.001). Conclusion: The early age at presentation and the poor control of risk factors, especially in patients from South East Asia and the Far East requires attention.
Introduction
Cerebrovascular disease is the second most common cause of death worldwide 1 and the leading cause of acquired disability in adults. [2] [3] [4] Compared to the developed countries, the risk is particularly high in developing countries where: (i) stroke presents at a younger age, 5 (ii) there is a lack of awareness and treatment of risk factors and (iii) poor management of the acute event causes higher mortality. [5] [6] [7] There has been a shift in populations across the world, leading to a major change in the demographic profile of several countries. 8 In many regions of the world, ethnically diverse populations are living together and in some countries, especially in the Middle East where, the expatriates outnumber the local population. Qatar has 2.4 million inhabitants (December 2014) comprised 88% by expatriates; 9 and 272,000 native Qataris. Major expatriate populations include 945,000 Southeast Asians, 400,000 non-Qatari Arabs and 200,000 people from the Far East. 9 In Qatar acute medical services, including hospital admissions are free of charge for all residents. However, comprehensive primary healthcare is lacking for most expatriates and many Qatari nationals. Higher education is lacking, especially in the South East Asian labour community, and vascular risk factors are poorly controlled. Studying vascular disease in such genetically distinct populations can provide pertinent informationabout risk profiles, pathogenesis and understanding the severity of the disease.
We report our experience with acute stroke in relationship to the ethnicity, risk factors, type and severity of stroke, risk of complications, 90-day prognosis and early recurrence in the state of Qatar.
Methods
Data from patients admitted with a stroke or transient ischemic attack (TIA) to Hamad General Hospital (HGH), Doha, Qatar from 1 January 2014 through 30 December 2015 were analysed from a hospitalbased prospective stroke registry. HGH is a Joint Commission International (JCI) accredited 600-bed hospital, with 200 beds reserved for medical patients. It is the only tertiary care medical facility in Qatar where the stroke service is located, 95% of all strokes in Qatar requiring admission to hospital are admitted to HGH. The stroke program, also certified by JCI, is a consultation service responsible for evaluation of all stroke patients admitted to the hospital. HGH is equipped with all the necessary laboratory, neuro-radiological and neurosurgical facilities and infrastructure required to manage acute stroke patients; HGH has a 24-hr thrombolysis and endovascular service. 10, 11 
Patient characteristics
Patient characteristics including age, sex, nationality, medical comorbidities and prior medication were collected into the Stroke Registry. Ethnicity was defined based on social groups sharing cultural and language traits within the broad categories of Arabs (Qatari and not-Qatari), South East Asians (Indian, Pakistani, Bangladeshi, Sri Lankans Nepalese and Myanmar) and the Far East (predominantly from Philippines). Data from the ambulance service, emergency department (ED), door-to-needle time (for thrombolysis patients), NIH Stroke Scale (NIHSS) score, length of stay (LoS) in ED, LoS in the stroke ward (SW) and general medical ward (GMW), completed investigations, timing of investigations, neuroimaging data, post-stroke complications, in-hospital mortality, and post-discharge disposition were entered into the registry. Ischemic stroke, TIAs and intracranial haemorrhage (ICH) were diagnosed according to the WHO criteria 12 and stroke subtypes by the TOAST criteria. 13 Thrombolysis-related hemorrhagic complications were defined according to the SITS-MOST criteria. 14 Symptomatic haemorrhage was defined by the SITS-MOST criteria as local or remote parenchymal hemorrhage on the 22-36 h post-treatment imaging scan, combined with a neurological deterioration of 4 points or more on the NIHSS from baseline, or from the lowest NIHSS value between baseline and 24 h, or leading to death. The modified Rankin scale (mRS) measurements were done at discharge and at 90 days following onset of symptoms. The patients were classified as good (mRS of 0-2) or poor (mRS 3-6) outcome. We used the dichotomised mRS scale as it the most commonly method in use to evaluate recovery at 90 days. 15 Diabetes was diagnosed according to the American Diabetes Association (ADA) and WHO recommendation 16 and included patients with a previous diagnosis of diabetes, on medication for diabetes or an HbA1c of more than 6.5%, and the diagnosis of pre-diabetes was based on an HbA1c of 5.7-6.4% as per the 2015 ADA clinical practice recommendations. Hypertension was defined as systolic blood pressure (BP) ! 140 mm Hg or a diastolic pressure ! 90 mm Hg, or on current treatment with antihypertensive drugs. We kept track of the number of patients with hypertension or diabetes who were unaware of these conditions at the time of presentation to the hospital. Dyslipidemia was defined as low-density lipoprotein-cholesterol level ! 3.62 mmol/L, high-density lipoprotein-cholesterol level 1.03 mmol/L, triglycerides ! 1.69 mmol/L, or current treatment with a cholesterol-lowering drug. Atrial fibrillation was diagnosed based on electrocardiographic findings on admission or on Holter monitoring during hospitalisation.
Smoking was defined as current cigarette smoking. BP and body mass index were measured on admission. Thrombolytic therapy was defined as intravenous administration of thrombolytic agents such as recombinant tissue type plasminogen activator.
Patients were admitted to the SW or the GMW and received acute care by a multidisciplinary team comprised stroke neurologists, clinical nurse specialists, coordinators, a nursing team trained in the care of stroke patients, stroke-trained physical, occupational, speech and language therapists and acute rehabilitation physicians. Specific attention was paid to preventative measures to minimise the risk of aspiration pneumonia, bladder infection, venous thrombosis and pressure ulcers. Approximately 75% of stroke patients were admitted to the geographically defined SW. The multidisciplinary team was also involved in the care of patients who were admitted to the GMW and the same stroke-care protocols as the SW were implemented in these patients.
Data collection
Upon identification and confirmation of diagnosis using the International Classification of Disease, 10th Edition, definitions (H34.1, I63.x, I64.x, I61.x, I60.x, G45.x), patients' data were collected by trained stroke coordinators. The ethnicities of the patients were recorded at admission.
Data analysis and statistics
Descriptive results for all continuous variables were reported as mean AE standard deviation (SD) (for normally distributed data) or median with range (for data not normally distributed 
Results

Patient characteristics
Diagnosis
Stroke diagnosis in the various ethnic groups is shown in Table 1 . Small vessel ischemic stroke was found in similar frequency in Middle Eastern patients 272/426 (63.8%) and in the Far Eastern group 80/122 (65.6%), but was significantly higher in South East Asian patients 464/689 (67.3%); p: 0.001. Cortical strokes were also significantly more common in Middle Eastern patients 110/594 (18.5%) and South East Asian patients 183/924 (19.8%). In patients from the Far East, cortical stroke was significantly lower 25/ 209 (12.0%); p < 0.001. A history of stroke, TIAs and coronary artery disease (CAD) was most commonly seen in the Middle Eastern patients ( Table 1) . Previous stroke or CAD was rare in Far Eastern patients. ICH was significantly higher in patients from the Far East (33.5%) compared to the Middle East (13.0%) and South East Asia (18.3%), p 0.001 (Table 1) . Stroke severity was found to be greater in the Far Eastern group (median (interquartile range (IQR)) -5.0 (2-11.5)) as compared to Middle Eastern group (median (IQR)-4.0 (1-8)) and South East Asian patients (median (IQR)-4.0 (2-9)), p ¼ 0.011 ( Table 2 ).
Reperfusion therapy
A total of 131 (11.0%) of ischemic stroke patients received reperfusion therapy with tissue plasminogen activator. It was highest for patients from South East Asia 87 (13.0%) and the Far East 16 (14.2%) and least frequent for Middle Eastern patients 28 (6.9%); p 0.004 (Table 1 ). There were no differences in means of transportation to the hospital (55% by ambulance), time from onset to arrival in hospital and 'doorto-needle' times within the ethnic groups. Reluctance to consent for thrombolysis from patient or family was seen in Middle Eastern patients. South East Asian patients were most frequently single men and 'two physicians consent' facilitated treatment in eligible patients.
Overall, the risk of post tissue plasminogen activator (tPA) symptomatic ICH was 5.3% ( (Figure 2) . The mRS at discharge was not significantly different between the three ethnic groups. Evaluation at 90 days revealed that patients from South East Asian had significantly better outcome (p ¼ 0.004) ( Table 2) , (also see supplemental Table 1 ). Compared to other ethnic groups, recurrent stroke was found to be more frequent in patients from the Middle East 22 (3.7%) compared to 14 (1.5%) in South East Asian patients and 3 (1.4%) in the Far Eastern group, p ¼ 0.019). Table 3 details a multiple binary logistic regression model to identify significant independent factors associated with ICH versus ischemic stroke after adjusting for demography in the three main ethnic groups. The adjusted OR and 95% confidence intervals are shown in Table 3 . The odds of having ICH among males were 1.57 times higher than females (p ¼ 0.057), while patients from the Far East have 2.84 times more likelihood of having ICH compared to patients from the Middle East (p < 0.001). The presence of hypertension was the most significant factor contributing to ICH with adjusted OR of 3.04 (95% CI: 1.99-4.61) after adjusting for age, gender and ethnicity. The lowering of serum cholesterol levels had significant adverse associated with ICH, while the presence of diabetes, prior stroke, CAD, and smoking significantly increases the risk of developing ischemic stroke (Table 3 ).
Risk factors associated with ischemic stroke versus intra-cerebral haemorrhage
Discussion
To the best of our knowledge, this is the first comprehensive prospective study reviewing the risk factors profile, clinical features and prognosis in a large, ethnically diverse population of stroke patients from the Middle East, South East Asia and the Far East. The age at presentation of stroke was significantly younger than reports from North America and Europe. There was a wide variance in the risk factor profile between the different ethnic groups. The combination of hypertension and diabetes (in Middle Eastern and South East Asian patients) was associated with increased risk of cortical and subcortical ischemic stroke, whereas the high rates of hypertension (with significantly lower rates of diabetes) were seen in patients from the Far East explained the rates of ICH. Symptoms on admission tended to be mild in most patients, including in patients presenting with ICH, accounting for the low mortality in our cohort. Higher rates of subcortical lacunar strokes with milder symptoms were likely secondary to poorly controlled hypertension and diabetes and may explain the better prognosis at 90 days. The results may be biased as we were able to conduct 90-day mRS telephone interviews in approximately 50% of patients. We cannot exclude the possibility that expatriate patients with severe deficits may have left Qatar following discharge from hospital.
Stroke presentation at a young age in the Middle East and South East Asia has previously been reported. 17, 18 Poor awareness and inadequate management of hypertension and diabetes may be important contributing factors. A lack of awareness of vascular risk factors has also been reported in the Qatar population with less than 30% aware that hypertension and diabetes were important risk factors. 19 A striking finding in our study was the high prevalence of dysglycaemia, especially in the Qatari population. The 67.6% is nearly double that of any previously reported prevalence of diabetes in stroke patients, which varied from 11% to 43%. 20 The prevalence of hypertension, especially untreated, was also very high in all the groups. The higher rates of sub-cortical 'lacunar' strokes presenting with milder symptoms, at a younger age is likely to be a result of the poor awareness and control of diabetes and hypertension. Significant difference in age and BMI between the three ethnic groups may be additional factors accounting for the higher rates of diabetes in Arabs compared to South East Asians.
In our cohort, South East Asian subjects had symptom profiles similar to what is reported from India and Pakistan. 21, 22 Presentation at a younger age and higher rates of subcortical lacunar stroke are likely related to the higher incidence of untreated hypertension and diabetes. 3, 21 A study with 289 patients from Pakistan showed hypertension (79%) and diabetes (52%) as the most common risk factors. 23 Jafar reported that a high salt intake and a higher incidence of diabetes and hypertension may be responsible for the strokes developing at a younger age in Pakistan. 24 . Direct comparisons of strokes in patients from South East Asia and Northern Europe descent are infrequent. Moussouttas et al. 25 compared clinical features in 99 South East Asian and 106 North European patients. Similar to our results, South East Asian patients were younger, had significantly higher rates of diabetes (48%), and subcortical stroke was double the rate observed in Caucasians. 25 In our study, patients from the Far East had the highest incidence of ICH. This is similar to the higher incidence of ICH reported in studies from Japan, China, Hong Kong, Taiwan, Philippines and Korea. 26, 27 Although hypertension being most common risk factor in patients from the Far East, its incidence was comparable to Middle Eastern patients and significantly higher than patients from South East Asia. Patients from the Far East however had significantly lower rates of diabetes when compared to the other ethnic groups in our study. Similar increased risk of ICH has been reported in Far Eastern immigrants settled in USA. 28 Amongst patients who died from an acute stroke in USA between 1995 and 1998, the underlying etiology was ICH in Far Eastern patients was 38% and 18% in Caucasian patients. 29 It is likely that genetic factors predispose the Far Eastern population to higher risk of ICH. The PRoFESS trial enrolled 20,332 patients in two-by-two factorial design comparing two dual antiplatelet regimens and telmisartan to placebo. Thirty-three percent of patients enrolled were of Far Eastern origin. The risk of ICH was significantly higher in this group, especially in individuals with hypertension (systolic BP > 150) compared to Caucasians. 30 Similarly, the risk of warfarinrelated ICH was four times higher in Far Eastern patients compared to Caucasians, 31 in patients treated for atrial fibrillation in a large cohort study from California. In an interesting comparison of stroke etiology in long-term residents in Hawaii, similar trends were evident. 32 There are a number of strengths in our study. This is the first study that reports on the magnitude of cerebrovascular disease in a diverse population. Cerebrovascular disease manifests at a younger age, especially in the patients from Southeast Asia and the Philippines. We report on high rates of undiagnosed or poorly controlled diabetes and hypertension, which was likely to have been a major contributor to the disease manifesting at an early age. The number of patients with pre-diabetes and diabetes was alarming and requires urgent attention. Similarly, despite the young age, there was disturbingly high incidence of hypertension in the patients. The higher rate of subcortical strokes seen in all ethnic groups is likely related to dysglycaemia and hypertension. The higher rates of ICH seen in patients from the Far East are also likely related to the hypertension. The population of Qatar largely consists of expatriates who do not stay in Qatar long term. The majority are blue-collar workers with very little education and lack awareness of the risk factors for vascular diseases. Our study identified the need to be more aggressive in the management of vascular risk factors in this population.
We acknowledge some limitations of this study. We do not know the prevalence of risk factors (diabetes, hypertension, dyslipidemia, atrial fibrillation and BMI) among the normal or non-stroke (control group) population in Qatar. We also do not know the duration of the diabetes and hypertension prior to the acute stroke or how well these conditions were treated prior to the stroke, although such data are often difficult to collect and have inherent inaccuracies. Lack of awareness of risk factors was a significant finding in our study. We did not collect patient data which could inform us about patients' awareness of stroke risk factors; level of education, household income, geographical location and occupation. These factors would be important to determine for preventive measures of vascular adverse events.
In conclusion, we report that stroke develops at a young age in Qatar. The high rates of subcortical stroke are likely related to the risk factor profile of the study population.
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